SOLVING KIDS' CANCER'S

RESEARCH PORTFOLIO 

SKC prioritizes and funds innovative preclinical research and early phase clinical trials with strong rationale for potential benefit to children with poor-prognosis cancers. The SKC approach involves collaborating with key stakeholders including scientists, clinicians, regulatory experts, and industry representatives to accelerate impactful advances globally. The mission-driven work of SKC has been carried out in over 210 cancer centers spanning 24 countries to date. Funded projects include 14 international studies and represent collaborations with 21 different charity partners.

2022 - 2023

2019 - 2021

2016 - 2018

2014 - 2015

2012 - 2013

2010 - 2011

2008 - 2009